Real Time In-Vivo Body Surface Dosimetry for External Beam Radiation Therapy

Completed

Conditions studied: Cancer of the Gastrointestinal, Genitourinary or Gynecologic Systems

In brief

This is an observational study. This protocol will determine the feasibility of using a novel nano-material based fiber-optic dosimeter (nanoFOD) device, with dimensions less than 1 mm wide, to measure real-time, pin-point, in-vivo radiation dose given during external beam delivery of radiation therapy treatments.This new protocol is similiar in design to Pro00050297 with the significant difference being the monitoring will be performed during external baem radiotherapy.

Key facts

Study ID

NCT02407977

Run by

Duke University

People needed

13

Starts

2015-11-13

Expected to finish

2017-04-19

Last updated by the study team

2018-10-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Histologically documented neoplasm of the pelvis (including gynecologic, gastrointestinal, and genitourinary origin).
• Planned external beam radiotherapy as part of standard of care treatment
• The radiotherapy plan involves the body surface
• Age > 18 years
• Able to provide and execute informed consent

You may not qualify if…

• Allergy or previous intolerance of skin adhesives
• Any clinical scenario in which the nanoFOD placement or reading would compromise the treatment efficacy, or endanger the patient in any way.

Where it is running

• Duke University Medica Center — Durham, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.